Charles Hurty - IShares Insurance Independent Trustee
| IAK Etf | USD 136.53 1.63 1.18% |
Mr. Charles A. Hurty is an Independent Trustee of iShares Dow Jones U.S. Insurance Index Fund ., since 2005. He is Chairman of the Audit Committee of the Company since 2006. Mr. Hurty has served as a Trustee of iShares Trust since 2005, Chairman of the Audit Committee of iShares Trust since 2006, a Director of iShares MSCI Russia Capped Index Fund, Inc. since 2010 and Chairman of the Audit Committee of iShares MSCI Russia Capped Index Fund, Inc. since 2010. In addition, Mr. Hurty serves as Director of the GMAM Absolute Return Strategy Fund since 2002, Director of the SkyBridge MultiAdviser Hedge Fund Portfolios LLC since 2002 and was a Director of the CSFB Alternative Investment Funds from 2005 to December 2009, when the funds were liquidated. Mr. Hurty was formerly a Partner at KPMG, LLP from 1968 to 2001
| Age | 72 |
| Tenure | 19 years |
| Issuer | iShares |
| Inception Date | 2006-05-01 |
| Benchmark | Dow Jones U.S. Select Insurance Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 800.3 Million |
| Average Trading Valume | 58,452 |
| Asset Type | Equity |
| Category | Sector |
| Focus | Financials |
| Market Concentration | Developed Markets |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| John Kerrigan | iShares Financial Services | 60 | |
| Madhav Rajan | iShares Regional Banks | 52 | |
| John Martinez | iShares Broker Dealers Securiti | 55 | |
| Robert Kapito | iShares Pharmaceuticals ETF | 62 | |
| John Martinez | iShares Financial Services | 55 | |
| Chad Hallett | SPDR SP Insurance | 46 | |
| Robert Silver | iShares Regional Banks | 57 | |
| Robert Silver | iShares Pharmaceuticals ETF | 57 | |
| Matthew Flaherty | SPDR SP Insurance | 41 | |
| George Parker | iShares Financial Services | 80 | |
| Robert Kapito | iShares Broker Dealers Securiti | 62 | |
| John Martinez | iShares Pharmaceuticals ETF | 55 | |
| Robert Silver | iShares Financial Services | 57 | |
| David Kelly | SPDR SP Insurance | 75 | |
| Madhav Rajan | iShares Pharmaceuticals ETF | 52 | |
| Eilleen Clavere | iShares Broker Dealers Securiti | 60 | |
| Helen Peters | SPDR SP Insurance | 71 | |
| Eilleen Clavere | iShares Regional Banks | 60 | |
| John Kerrigan | iShares Broker Dealers Securiti | 60 | |
| Robert Silver | iShares Broker Dealers Securiti | 57 | |
| John Clark | SPDR SP Insurance | 45 | |
iShares Insurance ETF Money Managers
| Geoffrey Flynn, Chief Operating Officer, Executive Vice President | ||
| Robert Silver, Independent Trustee | ||
| John Kerrigan, Independent Trustee | ||
| Madhav Rajan, Independent Trustee | ||
| Matt Tucker, Vice President | ||
| Cecilia Herbert, Independent Trustee | ||
| Michael Latham, President Director | ||
| Jack Gee, Chief Financial Officer, Treasurer | ||
| Charles Hurty, Independent Trustee | ||
| Eilleen Clavere, Secretary | ||
| George Parker, Independent Chairman of the Board of Trustee | ||
| John Martinez, Independent Trustee | ||
| Amy Schioldager, Executive Vice President | ||
| Robert Kapito, Trustee | ||
| Ira Shapiro, Vice President Chief Legal Officer |
IShares Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is IShares Insurance a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Price To Earning | 14.24 X | |||
| Price To Book | 1.08 X | |||
| Price To Sales | 1.15 X | |||
| Number Of Employees | 15 | |||
| Beta | 0.62 | |||
| Total Asset | 308.05 M | |||
| One Year Return | 40.70 % | |||
| Three Year Return | 22.60 % | |||
| Five Year Return | 16.30 % | |||
| Ten Year Return | 12.90 % |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Insurance ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
The market value of iShares Insurance ETF is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Insurance's value that differs from its market value or its book value, called intrinsic value, which is IShares Insurance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Insurance's market value can be influenced by many factors that don't directly affect IShares Insurance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Insurance's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Insurance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Insurance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.